ATE192648T1 - Verwendung von dioxabicyclo(3.3.0)octane zur behandlung und verhütung von zerebralen apoplexie - Google Patents

Verwendung von dioxabicyclo(3.3.0)octane zur behandlung und verhütung von zerebralen apoplexie

Info

Publication number
ATE192648T1
ATE192648T1 AT96300727T AT96300727T ATE192648T1 AT E192648 T1 ATE192648 T1 AT E192648T1 AT 96300727 T AT96300727 T AT 96300727T AT 96300727 T AT96300727 T AT 96300727T AT E192648 T1 ATE192648 T1 AT E192648T1
Authority
AT
Austria
Prior art keywords
dioxabicyclo
octane
treat
prevent cerebral
hypertension
Prior art date
Application number
AT96300727T
Other languages
English (en)
Inventor
Kengo Akimoto
Shiro Morimoto
Yasuo Matsumura
Hajime Yoshizumi
Tetsuo Murakami
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE192648T1 publication Critical patent/ATE192648T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96300727T 1995-02-01 1996-02-01 Verwendung von dioxabicyclo(3.3.0)octane zur behandlung und verhütung von zerebralen apoplexie ATE192648T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1527695 1995-02-01
JP7070205A JPH08268887A (ja) 1995-02-01 1995-03-28 高血圧症又はそれに起因する医学的症状の予防又は改善剤

Publications (1)

Publication Number Publication Date
ATE192648T1 true ATE192648T1 (de) 2000-05-15

Family

ID=26351395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96300727T ATE192648T1 (de) 1995-02-01 1996-02-01 Verwendung von dioxabicyclo(3.3.0)octane zur behandlung und verhütung von zerebralen apoplexie

Country Status (11)

Country Link
US (1) US5889046A (de)
EP (1) EP0729753B1 (de)
JP (1) JPH08268887A (de)
KR (2) KR100399671B1 (de)
AT (1) ATE192648T1 (de)
AU (1) AU705308B2 (de)
CA (1) CA2168513A1 (de)
DE (1) DE69608155T2 (de)
DK (1) DK0729753T3 (de)
ES (1) ES2145379T3 (de)
PT (1) PT729753E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180001A (ja) * 1997-09-08 1999-03-23 Toshihiko Osawa 高脂血症予防剤
US6737087B2 (en) * 2001-03-13 2004-05-18 Sung-jin Kim Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
US7357951B2 (en) * 2002-04-12 2008-04-15 Ajinomoto Co., Inc. Composition for preventing atherosclerosis
EP1637136A4 (de) * 2003-05-27 2007-08-01 Suntory Ltd Zusammensetzung mit autonomer nervenmodulierender aktivität und anwendungsverfahren dafür
EP1731521A1 (de) * 2004-03-31 2006-12-13 Suntory Limited Adiponectinerhöhendes mittel
WO2006016682A1 (ja) * 2004-08-09 2006-02-16 Suntory Limited 血管弾力性改善剤およびその使用
CA2592532C (en) * 2004-12-28 2015-02-17 Suntory Limited Sesamin/episesamin compositions with improved bioavailability
WO2006106986A1 (ja) * 2005-03-31 2006-10-12 Fuji Chemical Industry Co., Ltd. 血管不全改善剤
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
EP2002832A4 (de) 2006-03-31 2009-11-11 Suntory Holdings Ltd Zusammensetzung mit einer lignan-verbindung
JP5409989B2 (ja) * 2006-04-03 2014-02-05 サントリーホールディングス株式会社 セサミン類含有動物用飲食物
CN102813689B (zh) 2008-06-18 2016-08-10 株式会社资生堂 淋巴管的稳定剂
KR101124621B1 (ko) 2009-12-02 2012-03-19 한국생명공학연구원 세사민을 유효성분으로 함유하는 혈관신생 촉진제
KR20130046115A (ko) 2011-10-27 2013-05-07 (주)아모레퍼시픽 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
KR102016078B1 (ko) 2012-11-30 2019-08-30 (주)아모레퍼시픽 심장 질환 예방 또는 치료용 조성물
WO2014189347A1 (ko) * 2013-05-24 2014-11-27 한국생명공학연구원 유홍초속 식물 유래 신규 화합물 및 이를 유효성분으로 포함하는 당뇨병의 예방 또는 치료용 조성물
WO2020003363A1 (ja) * 2018-06-25 2020-01-02 学校法人近畿大学 ニコチン摂取の影響による血管の劣化を防止するための健康食品または医薬組成物
JP2023131584A (ja) * 2022-03-09 2023-09-22 淳三 亀井 抗炎症性マクロファージ活性化剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6112624A (ja) * 1984-06-27 1986-01-21 Zenyaku Kogyo Kk 抗高血圧剤
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
DK0409654T3 (da) * 1989-07-21 2001-12-27 Suntory Ltd Leverfunktionsforbedrende middel
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06112624A (ja) * 1992-09-28 1994-04-22 Matsushita Electric Ind Co Ltd 表面実装方法
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤

Also Published As

Publication number Publication date
AU705308B2 (en) 1999-05-20
EP0729753A1 (de) 1996-09-04
DE69608155T2 (de) 2000-09-28
KR20070108292A (ko) 2007-11-09
PT729753E (pt) 2000-10-31
DK0729753T3 (da) 2000-08-07
US5889046A (en) 1999-03-30
EP0729753B1 (de) 2000-05-10
KR960030937A (ko) 1996-09-17
JPH08268887A (ja) 1996-10-15
ES2145379T3 (es) 2000-07-01
AU4223696A (en) 1996-08-08
DE69608155D1 (de) 2000-06-15
CA2168513A1 (en) 1996-08-02
KR100399671B1 (ko) 2003-12-31

Similar Documents

Publication Publication Date Title
DE69608155D1 (de) Verwendung von Dioxabicyclo[3.3.0]octane zur Behandlung und Verhütung von zerebralen Apoplexie
AU6226494A (en) Spiroazacyclic derivatives as substance p antagonists
BR0315405A (pt) Compostos inibidores da integrase tricìclica pré-organizados
CA2263566A1 (en) Substituted 6,5-hetero-bicyclic derivatives
PT810209E (pt) Hidroxietilamino-sulfonamidas de alfa- e beta-aminoacidos uteis como inibidores de protease retroviral
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
TW226375B (de)
MXPA02012875A (es) Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su procedimiento de produccion e intermediario para producirlo.
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
ATE250031T1 (de) Tricyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz
EP0807633A3 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
ATE245418T1 (de) Verwendung von thiazolidindionen zur behandlung von atherosklerose und essstörungen
AU7713891A (en) Use of substituted 1,2,4-triazinediones
ATE202354T1 (de) Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz
AU1041497A (en) Epoxysuccinamide derivative or salt thereof and medicine comprising the same
ATE91128T1 (de) 5,11-dihydro-6h-dipyrido (3,2-b:2',3'-e>diazepin- 6-one und deren verwendung in der vorbeugung und behandlung von aids.
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE271786T1 (de) Dioxabicyclo 3.3.0 octan-derivate, z.b. sesamin etc., zur vorbeugung und erleichterung von allergiesymptomen
IE810698L (en) Pyranone derivatives
ATE71620T1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
EP0703232A3 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
DE69905489D1 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
AU2003246402A1 (en) Treatment of congenital disorders of glycosylation (cdg) using mannose
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner